Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors von Poulsen, Thomas Tuxen, Grandal, Michael Monrad, Skartved, Niels Jørgen Østergaard, Hald, Rikke, Alifrangis, Lene, Koefoed, Klaus, Lindsted, Trine, Fröhlich, Camilla, Pollmann, Sofie Ellebæk, Eriksen, Karsten Wessel, Dahlman, Anna, Jacobsen, Helle Jane, Bouquin, Thomas, Pedersen, Mikkel Wandahl, Horak, Ivan David, Lantto, Johan, Kragh, Michael

Volltext

Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor von SKARTVED, Niels Jørgen Østergaard, JACOBSEN, Helle Jane, PEDERSEN, Mikkel Wandahl, JENSEN, Pernille Foged, SEN, Jette Wagtberg, JORGENSEN, Thomas Kjærsgaard, HEY, Adam, KRAGH, Michael

Volltext

Population pharmacokinetics (popPK) of Sym004 to evaluate the effect of intrinsic and extrinsic factors on exposure in metastatic colorectal cancer (mCRC) von Alifrangis, Lene, Schoemacker, Rik, Skartved, Niels Jorgen Ostergaard, Hald, Rikke, Düring, Maria, Montagut, Clara, Argiles, Guillem, Kopetz, Scott, Horak, Ivan David, Kragh, Michael, Wade, Janet R

Volltext

Phase 1 study of biweekly (Q2W) anti-EGFR monoclonal antibody (mAb) mixture Sym004 in patients (pts) with metastatic colorectal cancer (mCRC) resistant to previous anti-EGFR treatm... von Argilés, Guillem, Dienstmann, Rodrigo, Benavent Viñuales, Marta, Cervantes, Andres, Rosello Keranen, Susana, H. Hansen, Ulla, Skartved, Niels Jorgen Ostergaard, Horak, Ivan David, Braun, Stephan, Garcia Carbonero, Rocio

Volltext

Sym004, a novel strategy to target EGFR with an antibody mixture, in patients with advanced SCCHN progressing after anti-EGFR monoclonal antibody: A proof of concept study von Machiels, Jean-Pascal H., Specenier, Pol M., Krauss, Jürgen, Dietz, Andreas, Kaminsky, Marie-Christine, Lalami, Yassine, Henke, Michael, Keilholz, Ulrich, Knecht, Rainald, Skartved, Niels Jorgen Ostergaard, Horak, Ivan David, Flensburg, Mimi F, Gauler, Thomas Christoph

Volltext

Proof-of-concept study of Sym004, an anti-EGFR monoclonal antibody (mAb) mixture, in patients (pts) with anti-EGFR mab-refractory KRAS wild-type (wt) metastatic colorectal cancer (... von Dienstmann, Rodrigo, Tabernero, Josep, Van Cutsem, Eric, Cervantes-Ruiperez, Andres, Rosello Keranen, Susana, Benavent Viñuales, Marta, Kjær, Ida, Pedersen, Mikkel W, Skartved, Niels Jorgen Ostergaard, Flensburg, Mimi F, Horak, Ivan David, Garcia-Carbonero, Rocio

Volltext